Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf your weight has been stable for a few weeks on Wegovy and the scales won't budge, you're not alone — and you haven't failed. Weight loss on semaglutide rarely follows a straight line; plateaus are a recognised part of the process, not a sign the medicine has stopped working. Understanding why they happen is the first step to working through them. Wegovy is a prescription-only medicine, so any changes to how you're managing your treatment should always be discussed with your prescriber rather than made independently.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: you've been on Wegovy for four months, you've noticed your appetite settle, you've lost weight steadily, and then, nothing. You step on the scales on a Wednesday morning with a cup of tea waiting to brew, and you're exactly where you were a fortnight ago. The immediate worry is that the medicine has stopped being effective. In most cases, that's not what's going on.
What's more likely is adaptive thermogenesis, the body's tendency to lower its resting energy expenditure as weight falls. Your metabolism is, in simple terms, running leaner because it has less to maintain. This is a predictable biological response, not a personal failing, and it affects almost everyone who loses a meaningful amount of weight, regardless of how they got there. The pattern of weight loss on Wegovy typically includes one or more plateau phases, particularly after the first few months.
There's also the question of what "stopped losing" means. A plateau that's lasted two weeks is different from one that's lasted eight. True stalls (where weight hasn't shifted in six weeks or more despite consistent adherence to treatment and a reduced-calorie diet) are worth discussing with your prescriber. Shorter flat periods often resolve on their own.
Several things influence when you stop losing weight on Wegovy, and knowing them helps you have a more productive conversation with a clinician. Starting weight matters: people with more weight to lose often see faster early progress and a more pronounced plateau later. If you're curious about when weight loss typically begins on Wegovy, understanding that early trajectory can help put a later slowdown into perspective. Your current dose matters too. If you haven't yet reached your maintenance dose, a prescriber may consider whether a dose increase is clinically appropriate, that decision is never yours to make unilaterally, but it's a reasonable conversation to raise.
Adherence to the lifestyle component of treatment also plays a meaningful role. Wegovy is licensed as an adjunct to a reduced-calorie diet and increased physical activity, and NHS guidance on semaglutide is clear that the medicine works alongside those changes, not instead of them. If eating patterns have drifted since the early weeks (which is common and understandable) a honest review of what's on your plate is worth doing before assuming the problem is pharmacological.
Sleep, stress, and hydration are less obvious but genuinely relevant. Chronic poor sleep raises cortisol, which can blunt weight-loss progress. None of this is a lecture, it's just the full picture a good prescriber will want to explore with you. You can read more about the broader clinical profile of semaglutide if you want to understand the mechanism in more depth.
First, give it time. Four to six weeks without a change is a more meaningful signal than two. Keep your pen stored correctly (refrigerated between 2°C and 8°C, and most people find the fridge door shelf works well for the once-weekly routine) and take each dose as directed by your prescriber and the patient information leaflet.
Second, book a clinical review. This is the most important practical step, and it's the one people often put off. A prescriber can look at your full picture: how long you've been at your current dose, whether a titration is due or appropriate, and whether any other factors (medicines, health changes, lifestyle shifts) are contributing. If you're using Wegovy through a private service, that review should be straightforward to access. At nume, a prescriber personally reviews every repeat order before it's dispensed, which creates a built-in checkpoint for exactly this kind of discussion.
Third, revisit the lifestyle component honestly. Protein intake tends to be the thing that slips most quietly. Keeping protein adequate helps preserve muscle as weight falls, and muscle is metabolically active tissue, losing it makes plateaus worse. A dietitian referral is worth considering if you haven't had structured dietary support. It's also worth understanding what happens to your weight if you stop Wegovy, since that context shapes how seriously to weigh up any long-term decisions about continuing treatment. The question of when to stop Wegovy only becomes relevant if progress has stalled long-term and all reasonable interventions have been tried.
NICE guidance on semaglutide (TA875) notes that if a person has lost less than 5% of their body weight after six months at the full maintenance dose, continuing treatment should be reviewed. That's a clinical threshold, not a trigger for self-discontinuation, it's a prompt for a structured conversation about whether the treatment is working well enough and what alternatives might be appropriate.
The NICE appraisal of Wegovy sets this in the context of its broader recommendation: Wegovy is intended to be used within a package of support, not as a standalone fix. If you've reached maintenance dose and weight hasn't moved in several months despite genuine adherence, a prescriber may discuss increasing to 7.2mg (now MHRA-approved as a single-dose pen), switching to a different medicine, or whether continuing at the current dose remains appropriate for you.
If you're wondering whether it's possible to simply plateau permanently on Wegovy, the honest answer is yes, and that's not always a problem. For some people, weight stabilisation at a lower level than their starting point is a meaningful clinical outcome, even if the scales aren't moving anymore. A prescriber is best placed to help you interpret what your plateau means in your specific context. If you'd like that kind of clinical support, you can start a free consultation with our prescribers and get a same-day clinical review.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.